BIOASTER
Christine Pohl, PhD, currently serves as the Strategic Partnership Manager for Vaccines at BIOASTER, a position held since February 2020. Prior to this role, Christine Pohl worked as a Manager and Senior Consultant at Executive Insight, Healthcare Consultants, from February 2013 to February 2020. Additionally, Christine Pohl gained experience as a Senior Consultant in Strategic Marketing within the Life Sciences sector at Alcimed from September 2009 to January 2013. Early career experience includes a Postdoctoral Researcher position at ENS Lyon from 2007 to 2009, as well as doctoral and postdoctoral research at The Julius Maximilians University of Würzburg from 2003 to 2007. Academic qualifications include a PhD in Virology from The Julius Maximilians University of Würzburg and a Master's degree in Microbiology from Leibniz Universität Hannover.
BIOASTER
1 followers
BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures. BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries. More information on www.bioaster.org